Managed Account Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Managed Account Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$6.55M	Sell	84,541 -41,566	-33%	-$2.73M	0.01%	1290
2015 Q1	$7.3M	Sell	126,107 -1,196	-0.9%	-$50.8K	0.01%	1233
2014 Q4	$4.11M	Sell	127,303 -5,559	-4%	-$167K	﹤0.01%	1488
2014 Q3	$3.25M	Sell	132,862 -4,597	-3%	-$93.4K	﹤0.01%	1583
2014 Q2	$2.44M	Sell	137,459 -5,265	-4%	-$84.8K	﹤0.01%	1711
2014 Q1	$2.86M	Buy	+142,724	New	+$2.77M	﹤0.01%	1591

Other funds holding ANAC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

Managed Account Advisors's ANAC Position: Q2 2015 in Review

Managed Account Advisors reduced its ANACOR PHARMACEUTICALS INC COM (ANAC) stake by 33% in Q2 2015, selling an estimated $2.73M and leaving 84,541 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #1290.

Managed Account Advisors first reported a position in ANAC in Q1 2014 and has held it in 6 quarters since. The position peaked at $7.3M in Q1 2015. 177 funds tracked by Wall St. Rank hold ANAC as of Q2 2015.

Managed Account Advisors held 84,541 shares of ANACOR PHARMACEUTICALS INC COM worth $6.55M as of Q2 2015.
Managed Account Advisors sold 41,566 ANACOR PHARMACEUTICALS INC COM shares in Q2 2015, an estimated $2.73M.
ANACOR PHARMACEUTICALS INC COM made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1290 holding.
Managed Account Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and has held it in 6 quarters since.
Managed Account Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $7.3M in Q1 2015.
177 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.